From the Factory to the Frontlines, the strategy for distributing a COVID-19 vaccine released by the Department of Health and Human Services Thursday, reflects commitment to important approaches to controlling this pandemic.
The U.S. Food and Drug Administration’s order changing the classification for tests used to measure cytomegalovirus loads in transplant patients is an important step in improving and making more accessible a critical tool for patient care management.
In a letter to U.S. Food and Drug Administration leaders today, more than 90 organizations representing physicians and other health providers, as well as scientists, patients and medical advocates, urge the agency to ensure that reviews of COVID-19 vaccine candidates meet all regulatory standards prior to authorization or licensure.
With funding from the Centers for Disease Control and Prevention, the Infectious Diseases Society of America has launched the COVID-19 Real-Time Learning Network microsite. The site brings together the latest clinical guidance, institutional protocols, clinical trials data, practice tools and resources from a variety of medical subspecialties around the world.
A new collection of articles, now available online, highlights the critical importance of nurturing a diverse next generation of infectious diseases specialists and leaders.
As the United Nations General Assembly opens for the first time in its 75-year history without an on-site gathering of world leaders, the critical need for international collaboration to end the current pandemic and prevent the next one should be clearer and more compelling than ever.
New guidance from the Infectious Diseases Society of America offers timely practice advice for the clinical treatment of three of the most common drug-resistant pathogens
In a new policy paper, IDSA and HIVMA call for urgent action to reduce illness and death associated with the overlapping epidemics of injection drug use and infectious diseases, outlining key steps needed now more than ever during the COVID-19 pandemic.
The Infectious Diseases Society of America and its HIV Medicine Association are urging the Food and Drug Administration to ensure rigorous safety and efficacy data support the approval of a COVID-19 vaccine before its widespread use by the public.
IDSA and HIVMA call for the immediate reversal of the abrupt revision of the CDC COVID-19 testing guidelines which diminish the importance of testing asymptomatic individuals who were exposed to COVID-19.